Vaxcyte Balance Sheet (2019-2026) | PCVX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Accumulated Depreciation (Quarter)	4.93M	5.42M	3.55M	4.12M	4.73M	5.42M	6.12M	6.83M	7.58M	8.38M	9.27M
Assets
Current Assets
Cash & Equivalents (Quarter)	151.00M	112.04M	68.98M	201.74M	238.17M	278.40M	834.66M	380.45M	531.03M	545.13M	397.45M	611.51M	518.67M	1,050.19M	387.88M	346.85M	306.74M	281.08M	173.96M	260.84M
Receivables - Net (Quarter)	0.40M	5.00M	1.20M	0.10M	0.70M	0.70M	1.00M		2.40M	1.90M		0.10M	0.40M	0.30M	0.40M		0.10M	0.40M
Receivables - Other (Quarter)	0.70M						2.85M			3.44M	3.60M	8.02M	8.08M	17.57M	20.26M				21.36M
Receivables (Quarter)	1.10M	5.00M	1.20M	0.10M	0.70M	0.70M	3.85M		2.40M	5.34M	3.60M	8.12M	8.48M	17.87M	20.66M		0.10M	0.40M	21.36M
Prepaid Assets (Quarter)	9.42M	24.37M	10.38M	7.58M	9.23M	7.53M	11.18M	18.64M	23.25M	15.34M	15.73M	2.09M	28.78M	3.44M	40.78M	44.83M	54.35M	55.85M	66.40M	76.31M
Current Assets (Quarter)	301.53M	302.95M	256.35M	342.22M	363.73M	369.76M	942.55M	840.67M	1,310.32M	1,295.43M	1,095.95M	1,517.07M	1,481.48M	2,213.86M	1,787.98M	1,716.56M	1,715.78M	1,767.17M	1,627.36M	1,813.49M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	5.66M	6.63M	7.95M	10.14M	10.18M	9.95M	10.36M	15.21M	16.42M	11.43M	79.63M	84.83M	125.97M	163.24M	198.04M	217.16M	242.27M	253.49M	257.37M	260.69M
Long-Term Investments (Quarter)	48.84M	39.73M	27.12M	17.70M	6.86M	3.98M	26.55M	127.81M	153.73M	168.56M	162.68M	413.25M	399.24M	1,092.57M	1,387.51M	1,279.03M	1,165.09M	959.26M	881.66M	1,004.02M
Other Non-Current Assets (Quarter)	0.87M	0.87M	0.87M	5.67M	5.43M	0.87M	0.87M	3.94M	3.48M	1.10M	1.10M	1.10M	1.10M	1.32M	64.36M	1.32M	95.26M	1.47M	118.85M	155.54M
Non-Current Assets (Quarter)	56.52M	51.12M	67.99M	60.49M	47.89M	42.31M	63.62M	167.49M	192.50M	200.62M	311.96M	574.23M	605.79M	1,345.88M	1,723.33M	1,661.54M	1,589.59M	1,404.43M	1,375.36M	1,534.82M
Assets (Quarter)	358.05M	354.07M	324.34M	402.72M	411.62M	412.06M	1,006.18M	1,008.16M	1,502.82M	1,496.06M	1,407.92M	2,091.30M	2,087.27M	3,559.75M	3,511.32M	3,378.10M	3,305.36M	3,171.60M	3,002.72M	3,348.31M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	23.70M	25.71M	6.76M	4.80M	7.04M	5.49M	9.79M	11.62M	16.27M	15.70M	14.59M	21.72M	10.47M	18.22M	48.45M	20.51M	31.41M	48.96M	70.90M	63.06M
Payables (Quarter)	23.70M	25.71M	6.76M	4.80M	7.04M	5.49M	9.79M	11.62M	16.27M	15.70M	14.59M	21.72M	10.47M	18.22M	48.45M	20.51M	31.41M	48.96M	70.90M	63.06M
Accumulated Expenses (Quarter)	7.53M	12.03M	3.46M	7.74M	9.89M	13.68M	15.38M	1.88M	4.42M	15.02M	11.06M	54.17M	6.46M	30.75M	29.12M	26.04M	10.83M	24.59M	31.07M	7.99M
Other Accumulated Expenses (Quarter)	3.96M	5.05M	3.66M	0.97M	0.93M	1.58M	1.41M	2.70M	1.91M	2.49M	1.90M
Current Leases (Quarter)	0.71M	0.61M	5.28M	6.58M	6.64M	6.43M	5.91M	5.95M	5.99M	6.03M	7.11M	7.20M	7.29M	9.64M	5.89M	6.13M	6.30M	5.77M	6.12M	6.08M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	40.70M	47.46M	28.72M	27.25M	30.47M	39.31M	40.52M	52.75M	60.22M	85.56M	145.34M	87.10M	82.85M	123.79M	140.18M	97.00M	154.49M	200.05M	205.75M	242.08M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)	0.23M	0.55M	12.90M	15.83M	14.56M	13.36M	12.90M	10.64M	9.22M	7.78M	22.11M	20.22M	25.58M	18.32M	65.22M	81.08M	85.84M	78.67M	111.46M	110.21M
Other Non-Current Liabilities (Quarter)	0.10M	0.10M	0.10M	0.09M	0.09M	0.09M	0.01M	0.01M	0.01M	0.00M					0.10M				0.10M
Total Non-Current Liabilities (Quarter)	40.93M	48.01M	40.22M	43.08M	45.03M	52.66M	52.56M	63.38M	69.44M	93.34M	167.45M				205.40M				317.11M
Total Liabilities (Quarter)	41.03M	48.11M	40.32M	43.17M	45.12M	52.75M	52.56M	63.39M	69.44M	93.34M	167.45M	107.32M	101.14M	142.11M	205.50M	178.08M	234.03M	278.72M	317.21M	352.29M
Shareholder's Equity
Common Equity (Quarter)	317.02M	305.96M	284.02M	359.54M	366.50M	359.31M	953.61M	944.77M	1,433.38M	1,402.72M	1,240.47M	1,983.98M	1,986.13M	3,417.63M	3,305.82M	3,200.03M	3,071.33M	2,892.88M	2,685.51M	2,996.01M
Shareholder's Equity (Quarter)	317.02M	305.96M	284.02M	359.54M	366.50M	359.31M	953.61M	944.77M	1,433.38M	1,402.72M	1,240.47M	1,983.98M	1,986.13M	3,417.63M	3,305.82M	3,200.03M	3,071.33M	2,892.88M	2,685.51M	2,996.01M
Liabilities and Shareholders Equity (Quarter)	358.05M	354.07M	324.34M	402.72M	411.62M	412.06M	1,006.18M	1,008.16M	1,502.82M	1,496.06M	1,407.92M	2,091.30M	2,087.27M	3,559.75M	3,511.32M	3,378.10M	3,305.36M	3,171.60M	3,002.72M	3,348.31M
Retained Earnings (Quarter)	-0.01M	-0.01M	-298.64M	-337.63M	-386.16M	-0.66M	-522.13M	0.05M	-650.93M	-743.59M	0.18M	-1019.41M	-1148.12M	0.14M	-1388.32M	-1529.04M	-1695.61M	0.86M	-2154.95M	-2475.57M
Treasury Shares (Quarter)				0.37M	0.43M	0.42M	0.46M	0.77M	0.80M	0.70M	0.75M	1.74M	0.18M	1.15M	1.24M		2.08M	2.37M	0.18M	3.33M
Shares Outstanding (Quarter)	51.96M	52.59M	53.03M	56.50M	58.62M	60.57M	79.47M	80.64M	93.81M	95.10M	95.36M	108.76M	110.58M	124.43M	124.89M	128.94M	129.82M	130.03M	131.06M	144.31M

Research Tools

Developers

Vaxcyte Balance Sheet (2019-2026) | PCVX

Research Tools

Developers

Vaxcyte Balance Sheet (2019-2026) | PCVX

Create an account

Sign In

Reset Password